Anil Pooran

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study

Elize Pietersen, Elisa H. Ignatius, Elizabeth M. Streicher et al. · The Lancet · 2014 · 250 citations

Pulmonary Tuberculosis, Treatment And Prevention, Tuberculosis Prevention +11

What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?

Anil Pooran, Elize Pieterson, Malika Davids et al. · PLoS ONE · 2013 · 231 citations · Full text

Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis

Keertan Dheda, Laura Lenders, Gesham Magombedze et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 160 citations · Full text